Product Image

Contributor Information

  • Institute Erasmus University Medical Center (Erasmus MC)

Tool Details

  • Tool name: ZR-75-1 estrogen independent breast cancer cell line panel (1)
  • Alternate names: BCAR
  • Tool type: Cell Lines
  • Tool sub-type: Continuous
  • Parental cell line: ZR-75-1
  • Organism: Human
  • Tissue: Breast
  • Cancer type: Mammary ductal carcinoma, estrogen independent
  • Disease: Cancer
  • Description: Endocrine therapy of breast cancer has been applied widely and proven to be effective. However, in many instances endocrine treatments ultimately fail due to the development of an estrogen-independent therapy resistant phenotype. To elucidate the molecular mechanism underlying this endocrine therapy failure, the laboratory of Lambert Dorssers applied random insertional mutagenesis using defective retroviruses to identify individual genes conferring estrogen independence. Viral integrations were mapped within the human genome of the resulting panel of 71 tamoxifen-resistant cells lines (Cat No 154549-154619). Out of 15 candidate BCAR genes, seven were shown to directly underlie estrogen independence. These cell lines are a powerful tool for studying the molecular and cellular mechanisms of breast tumour progression, therapy resistance and to test the effectiveness of novel drugs to combat different modes of anti-estrogen insensitivity.
  • Research area: Cancer ; Drug Discovery & Development

  • For Research Use Only

Target Details

Application Details

Handling

  • Format: Frozen
  • Growth medium: RPMI 1640 medium supplemented with 10% heat-inactivated bovine calf serum (RBCS)
  • Shipping conditions: Dry ice

Documentation

  • Available on request

References

  •   van Agthoven et al. 2009. Breast Cancer Res Treat. 114(1):23-30. PMID: 18351453.
  •   Dorssers et al. 1993. Mol Endocrinol. 7(7):870-8. PMID: 8413311.